Kelly Timothy E.'s most recent trade in Praxis Precision Medicines Inc was a trade of 943 Common Stock done at an average price of $275.7 . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.74 per share. | 12 Jan 2026 | 943 | 31,046 | - | 275.7 | 260,023 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 8,800 | 33,324 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 7,040 | 7,040 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 288.45 per share. | 08 Jan 2026 | 1,335 | 31,989 | - | 288.5 | 385,081 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.63 per share. | 07 Jan 2026 | 139 | 24,524 | - | 292.6 | 40,676 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 31.62 per share. | 14 Nov 2025 | 384 | 24,663 | - | 31.6 | 12,142 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 31.53 per share. | 14 May 2025 | 249 | 24,279 | - | 31.5 | 7,852 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 12,500 | 24,706 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.15 per share. | 10 Jan 2025 | 676 | 24,030 | - | 63.1 | 42,689 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.52 per share. | 07 Jan 2025 | 139 | 12,206 | - | 77.5 | 10,775 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 37.40 per share. | 14 Nov 2024 | 205 | 12,345 | - | 37.4 | 7,667 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 36,400 | 36,400 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 7,800 | 12,140 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 12.37 per share. | 14 May 2024 | 606 | 4,340 | - | 12.4 | 7,495 | Common Stock |
| Praxis Precision Medicines Inc | Kelly Timothy E. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy Kelly E. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.19 per share. | 07 Jan 2024 | 139 | 3,734 | - | 25.2 | 3,501 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 12 May 2023 | 11,683 | 58,099 | - | 0.9 | 10,328 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 24 Mar 2023 | 8,000 | 46,416 | - | 0.9 | 6,998 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 42,455 | 42,455 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 07 Jan 2023 | 2,079 | 38,416 | - | 2.5 | 5,239 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.80 per share. | 14 Nov 2022 | 5 | 40,495 | - | 1.8 | 9 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 09 Jun 2022 | 10,000 | 40,490 | - | 1.8 | 17,650 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 8.80 per share. | 13 May 2022 | 2,585 | 30,490 | - | 8.8 | 22,743 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 84,000 | 84,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 24,000 | 27,905 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 19.48 per share. | 31 Aug 2021 | 3,905 | 3,905 | - | 19.5 | 76,069 | Common Stock |
| Praxis Precision Medicines Inc | Timothy E. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) |